EUVIMEDDescoperă EUVIMED
MetaanalyseSystematische ÜbersichtOpen access · CC BY 4.0

Duration‐Dependent Cardiac Effects of Anabolic‐Androgenic Steroid Use in Strength‐Trained Athletes: A Systematic Review and Meta‐Analysis

Matheus de Medeiros Fernandes iD, Pedro Gomes Batista iD, Camila Viviane Ribera Chagas iD, Railla Raquel Albino Dos Santos Silva iD, Fernanda Medeiros Santos iD, Miguel Chaves Lenzi iD, Felipe de Medeiros Fernandes iD, Ranna Santos Pessoa iD, Patrícia Jovelina de Freitas iD, Flávio Henrique Amaral Pires Véras iD, Stephan Barisic Junior iD, Douglas Nunes Cavalcante iD and 2 more

Echocardiography · 2026

DOI: 10.1111/echo.70611 ↗

At a glance

Metaanalyse in Echocardiography, 2026. Written by Matheus de Medeiros Fernandes and 13 co-authors. Institution: Medicine Department, State University of Rio Grande Do Norte (UERN), Mossoró, Brazil. Major MEDLINE topics: Anabolic Androgenic Steroids, Athletes, Heart, Ventricular Function, Left. 74 references. The full text is freely available (open access, CC BY 4.0).

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Purpose

Nonmedical anabolic‐androgenic steroid (AAS) use is increasing, and its duration‐dependent cardiac effects remain unclear. We evaluated cardiac structure and function in AAS‐using strength‐trained athletes, overall and by exposure duration.

Methods

We searched PubMed, Embase, Cochrane Central, and SCOPUS through November 2025 for observational studies comparing AAS‐using and nonusing strength‐trained athletes of either sex. Random‐effects models pooled mean differences (MD) overall and across four exposure strata (6 years); meta‐regression assessed duration as a continuous moderator.

Results

Forty studies (1906 athletes; 95% male) were included. Overall, AAS users showed reduced left ventricular ejection fraction (LVEF; 29 studies; MD −2.84%; 95% CI −4.24 to −1.44; p < 0.01), impaired global longitudinal strain (GLS; MD +3.27%; p < 0.01), and increased left ventricular mass index (LVMI; MD +18.21 g/m 2 ; p < 0.01). Septal thickening was detectable before six months, preceding functional impairment. LVEF, LVMI, and posterior wall thickness (PWT) differed significantly across strata (all p ≤ 0.03), with the largest LVEF reduction beyond six years (MD −7.39%; 95% CI −10.71 to −4.07). Meta‐regression suggested that exposure duration was associated with variation in selected structural and functional outcomes, corroborating LVEF, LVMI, and PWT, while GLS, E/e′, and E/A ratio showed no significant association. Right ventricular strain was impaired in an exploratory, non‐stratified analysis.

Conclusion

AAS use is associated with cardiac structural and functional abnormalities, with exposure duration associated with selected, but not all, outcomes. These cross‐sectional comparisons do not establish within‐person progression; longitudinal surveillance with deformation imaging is warranted.

Subjects

MeSH terms (MEDLINE)

Anabolic Androgenic SteroidsAthletesHeartVentricular Function, LeftHumansEchocardiographyGlobal Longitudinal StrainHeart VentriclesObservational Studies as TopicStroke Volume

Author keywords

anabolic steroidsathletescardiac remodelingechocardiographyglobal longitudinal strain

Substances

Anabolic Androgenic Steroids

Authors and institutions

  • Medicine Department, State University of Rio Grande Do Norte (UERN), Mossoró, Brazil.
  • Medicine Department, Federal University of Paraíba (UFPB), João Pessoa, Brazil.
  • Medicine Department, Federal University of Ceará (UFC), Fortaleza, Brazil.
  • Medicine Department, Federal University of Rio Grande Do Norte (UFRN), Natal, Brazil.
  • Hospital Israelita Albert Einstein, Goiânia, Brazil.
  • Sírio Libanês Hospital, São Paulo, Brazil.

ORCID profiles: Matheus de Medeiros Fernandes, Pedro Gomes Batista, Camila Viviane Ribera Chagas, Railla Raquel Albino Dos Santos Silva, Fernanda Medeiros Santos, Miguel Chaves Lenzi, Felipe de Medeiros Fernandes, Ranna Santos Pessoa, Patrícia Jovelina de Freitas, Flávio Henrique Amaral Pires Véras, Stephan Barisic Junior, Douglas Nunes Cavalcante, Juliana Giorgi, Caroline Fischer-Bacca

Cite

APA

Fernandes, M. M., Batista, P. G., Chagas, C. V. R., Silva, R. R. A. D. S., Santos, F. M., Lenzi, M. C., Fernandes, F. M., Pessoa, R. S., de Freitas, P. J., Véras, F. H. A. P., Junior, S. B., Cavalcante, D. N., Giorgi, J., & Fischer-Bacca, C. (2026). Duration‐Dependent Cardiac Effects of Anabolic‐Androgenic Steroid Use in Strength‐Trained Athletes: A Systematic Review and Meta‐Analysis. Echocardiography. https://doi.org/10.1111/echo.70611

Vancouver

Fernandes MM, Batista PG, Chagas CVR, Silva RRADS, Santos FM, Lenzi MC, et al. Duration‐Dependent Cardiac Effects of Anabolic‐Androgenic Steroid Use in Strength‐Trained Athletes: A Systematic Review and Meta‐Analysis. Echocardiography. 2026. doi:10.1111/echo.70611

BibTeX
@article{Fernandes2026,
  author = {Fernandes, Matheus de Medeiros and Batista, Pedro Gomes and Chagas, Camila Viviane Ribera and Silva, Railla Raquel Albino Dos Santos and Santos, Fernanda Medeiros and Lenzi, Miguel Chaves and Fernandes, Felipe de Medeiros and Pessoa, Ranna Santos and de Freitas, Patrícia Jovelina and Véras, Flávio Henrique Amaral Pires and Junior, Stephan Barisic and Cavalcante, Douglas Nunes and Giorgi, Juliana and Fischer-Bacca, Caroline},
  title = {Duration‐Dependent Cardiac Effects of Anabolic‐Androgenic Steroid Use in Strength‐Trained Athletes: A Systematic Review and Meta‐Analysis},
  journal = {Echocardiography},
  year = {2026},
  doi = {10.1111/echo.70611}
}
Start for free →